COMBINEDBrain – Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders

The Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders is a non-profit consortium led by patient advocacy foundations, working with the clinicians, researchers and pharmaceutical firms that are developing treatments for the disorders they represent. They are devoted to speeding the path to clinical treatments for people with rare genetic neurological disorders by pooling efforts, studies, and data.